Publication:
Financing, Pricing, and Utilization of Pharmaceuticals in China: The Road to Reform

Simple item page
dc.contributor.authorWorld Bank
dc.date.accessioned2017-07-17T19:54:45Z
dc.date.available2017-07-17T19:54:45Z
dc.date.issued2010
dc.description.abstractThis paper examines the financing, pricing, and utilization of pharmaceuticals in China the pharmaceutical system as it has evolved, and some changes that would improve it in the context of the national health reform process. The present paper builds upon earlier critical reviews and other papers published in the series china health policy notes. The paper is divided into four parts. The first section provides an overview of the Chinese pharmaceutical market: how the sector has grown; China's position in the global market; and size, composition, and trends in the domestic market. The second section examines the evolution and status of China's system of essential medicines, an area emphasized in the government's health reform plan announced in April 2009. It shows how the use of essential medicines has evolved over the two decades since the idea was formally adopted, and discusses why practice has fallen far short of the ideal. The third section looks at the issue that dominates today's debate: managing high pharmaceutical costs. It reviews the components of drug pricing, underscoring the argument that there is considerable scope for reducing prices. It looks at government attempts to control drug prices, and suggests why they did not succeed. Finally, the fourth section suggests measures to re-chart the path to reform.en
dc.identifierhttp://documents.worldbank.org/curated/en/933311468216270181/Main-report
dc.identifier.doi10.1596/27598
dc.identifier.urihttps://hdl.handle.net/10986/27598
dc.languageEnglish
dc.language.isoen_US
dc.publisherWashington, DC
dc.relation.ispartofseriesChina Health Policy Notes;No. 1
dc.rightsCC BY 3.0 IGO
dc.rights.holderWorld Bank
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/igo
dc.subjectACCESS TO PHARMACEUTICALS
dc.subjectACCOUNTABILITY
dc.subjectACCOUNTING
dc.subjectACTIVE INGREDIENTS
dc.subjectADVERTISING
dc.subjectAGGRESSIVE
dc.subjectAGING
dc.subjectANALGESICS
dc.subjectANESTHESIA
dc.subjectANTIBIOTICS
dc.subjectAVERAGE PRICE
dc.subjectBENCHMARKS
dc.subjectBIDDING
dc.subjectBLOOD PRODUCTS
dc.subjectBRAND
dc.subjectBRAND NAME
dc.subjectBRAND NAME DRUGS
dc.subjectBRAND NAMES
dc.subjectBUDGETING
dc.subjectCAPACITY BUILDING
dc.subjectCENTER FOR HEALTH
dc.subjectCHINESE POPULATION
dc.subjectCHRONIC CONDITIONS
dc.subjectCHRONIC DISEASES
dc.subjectCITIZENS
dc.subjectCLINICAL GUIDELINES
dc.subjectCLINICAL TRIALS
dc.subjectCOMMUNITY HEALTH
dc.subjectCOMMUNITY PHARMACIES
dc.subjectCOMPETITIVE BIDDING
dc.subjectCOOPERATIVE MEDICAL INSURANCE
dc.subjectCORRUPTION
dc.subjectDEVELOPING COUNTRIES
dc.subjectDIABETES
dc.subjectDIFFERENTIAL PRICING
dc.subjectDISSEMINATION
dc.subjectDOMESTIC EXPENDITURES
dc.subjectDOMESTIC MANUFACTURERS
dc.subjectDOMESTIC MARKET
dc.subjectDONATIONS
dc.subjectDOSAGES
dc.subjectDRUG PRESCRIBING
dc.subjectDRUG PRICES
dc.subjectDRUGS
dc.subjectECONOMIC TRANSITION
dc.subjectESSENTIAL DRUGS
dc.subjectESSENTIAL MEDICINES
dc.subjectEXPENDITURE
dc.subjectEXPENDITURES
dc.subjectEXPORT MARKET
dc.subjectFAMILIES
dc.subjectFAMILY PLANNING
dc.subjectFEES FOR SERVICES
dc.subjectGENERIC DRUGS
dc.subjectGMP
dc.subjectGOOD MANUFACTURING PRACTICES
dc.subjectHEALTH CARE
dc.subjectHEALTH CENTERS
dc.subjectHEALTH FACILITIES
dc.subjectHEALTH INSURANCE
dc.subjectHEALTH POLICY
dc.subjectHEALTH REFORM
dc.subjectHEALTH SECTOR
dc.subjectHEALTH SERVICES
dc.subjectHEALTH SYSTEM
dc.subjectHOSPITAL
dc.subjectHOSPITAL PHARMACIES
dc.subjectHOSPITALS
dc.subjectHYPERTENSION
dc.subjectILLNESS
dc.subjectIMMUNIZATION
dc.subjectIMPORTED DRUGS
dc.subjectINFORMATION SYSTEM
dc.subjectINSURANCE SCHEMES
dc.subjectIRRATIONAL USE
dc.subjectLARGE CITIES
dc.subjectLOCAL GOVERNMENTS
dc.subjectMARKET PRICE
dc.subjectMARKET PRICES
dc.subjectMARKET SHARE
dc.subjectMARKETING
dc.subjectMARKETPLACE
dc.subjectMEDICAL EDUCATION
dc.subjectMEDICAL INSURANCE
dc.subjectMEDICAL SERVICES
dc.subjectMEDICATION
dc.subjectMEDICINE
dc.subjectMEDICINES
dc.subjectMENTAL HEALTH
dc.subjectMINISTRY OF HEALTH
dc.subjectMONOPOLIES
dc.subjectNATIONAL DEVELOPMENT
dc.subjectNATIONAL DRUG
dc.subjectNATIONAL ESSENTIAL DRUG LISTS
dc.subjectNATIONAL LEVEL
dc.subjectNATIONAL POLICY
dc.subjectNDP
dc.subjectNURSES
dc.subjectNUTRITION
dc.subjectPACKAGING
dc.subjectPATENTS
dc.subjectPATIENT
dc.subjectPATIENTS
dc.subjectPHARMACEUTICAL
dc.subjectPHARMACEUTICAL COMPANIES
dc.subjectPHARMACEUTICAL COST CONTAINMENT
dc.subjectPHARMACEUTICAL COSTS
dc.subjectPHARMACEUTICAL DISTRIBUTION
dc.subjectPHARMACEUTICAL EXPENDITURE
dc.subjectPHARMACEUTICAL INDUSTRY
dc.subjectPHARMACEUTICAL LAW
dc.subjectPHARMACEUTICAL MANUFACTURERS
dc.subjectPHARMACEUTICAL MANUFACTURING
dc.subjectPHARMACEUTICAL PRICES
dc.subjectPHARMACEUTICAL PRICING
dc.subjectPHARMACEUTICAL PRODUCTS
dc.subjectPHARMACEUTICAL QUALITY
dc.subjectPHARMACEUTICAL REFORM
dc.subjectPHARMACEUTICAL SECTOR
dc.subjectPHARMACEUTICAL SUPPLY
dc.subjectPHARMACEUTICALS
dc.subjectPHARMACOECONOMIC EVALUATION
dc.subjectPHARMACY
dc.subjectPHYSICIANS
dc.subjectPOOLED PROCUREMENT
dc.subjectPOOR FAMILIES
dc.subjectPRESCRIPTIONS
dc.subjectPREVENTIVE HEALTH CARE
dc.subjectPRICE ADJUSTMENTS
dc.subjectPRICE CAPS
dc.subjectPRICE CHANGES
dc.subjectPRICE CONTROL
dc.subjectPRICE CONTROLS
dc.subjectPRICE INCREASES
dc.subjectPRICE LIST
dc.subjectPRICE REGULATION
dc.subjectPRICE SETTING
dc.subjectPRICING POLICIES
dc.subjectPRICING POLICY
dc.subjectPROCUREMENT
dc.subjectPUBLIC DEBATE
dc.subjectPUBLIC HEALTH
dc.subjectPUBLIC HEALTH SERVICES
dc.subjectPUBLIC HEARINGS
dc.subjectPUBLIC HOSPITALS
dc.subjectPURCHASING
dc.subjectQUALITY ASSURANCE
dc.subjectQUALITY CONTROL
dc.subjectQUALITY OF LIFE
dc.subjectREBATES
dc.subjectRETAIL
dc.subjectRETAIL PRICE
dc.subjectRETAIL PRICES
dc.subjectRURAL AREAS
dc.subjectSALE
dc.subjectSALES
dc.subjectSCIENTIFIC EVIDENCE
dc.subjectSOCIAL CONSEQUENCES
dc.subjectSOCIAL HEALTH INSURANCE
dc.subjectSOCIAL POLICY
dc.subjectSOCIAL SECURITY
dc.subjectSOCIAL WELFARE
dc.subjectSPECIFIC INCENTIVES
dc.subjectSTATE PLANNING
dc.subjectSUBSTITUTE
dc.subjectSUPPLY CHAIN
dc.subjectSURGERY
dc.subjectSURPLUS
dc.subjectTENDERING
dc.subjectTRADITIONAL MEDICINES
dc.subjectTREATMENT GUIDELINES
dc.subjectURBAN AREAS
dc.subjectURBAN CENTERS
dc.subjectURBAN COMMUNITY
dc.subjectVACCINES
dc.subjectWHOLESALE PRICE
dc.subjectWORKERS
dc.subjectWORLD HEALTH ORGANIZATION
dc.titleFinancing, Pricing, and Utilization of Pharmaceuticals in Chinaen
dc.title.subtitleThe Road to Reformen
dc.typePolicy Noteen
dc.typeDocument de politique généralefr
dc.typeDocumento de políticases
dspace.entity.typePublication
okr.crossref.titleFinancing, Pricing, and Utilization of Pharmaceuticals in China
okr.date.disclosure2010-12-14
okr.date.doiregistration2025-05-07T10:17:57.262685Z
okr.doctypeEconomic & Sector Work::Policy Note
okr.doctypeEconomic & Sector Work
okr.docurlhttp://documents.worldbank.org/curated/en/933311468216270181/Main-report
okr.guid147681468010854943
okr.guid590351468018625366
okr.guid933311468216270181
okr.guid432011468215971547
okr.identifier.externaldocumentum000333038_20101215014751
okr.identifier.internaldocumentum13240680
okr.identifier.report58410
okr.importedtrue
okr.language.supporteden
okr.pdfurlhttp://documents.worldbank.org/curated/en/933311468216270181/pdf/584100NWP0V20P1No11Pharma0Financing.pdfen
okr.region.administrativeEast Asia and Pacific
okr.region.countryChina
okr.sectorHealth and other social services :: Health
okr.topicHealth, Nutrition and Population::Health Monitoring & Evaluation
okr.topicHealth, Nutrition and Population::Pharmaceuticals & Pharmacoeconomics
okr.topicInternational Economics and Trade::Access to Markets
okr.unitHNP Sector Unit (EASHH)
Files
Original bundle
Now showing 1 - 2 of 2
Thumbnail Image
Name:
584100NWP0V20P1No11Pharma0Financing.pdf
Size:
1.41 MB
Format:
Adobe Portable Document Format
Download
No Thumbnail Available
Name:
584100NWP0V20P1No11Pharma0Financing.txt
Size:
159.23 KB
Format:
Plain Text
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Plain Text
Description:
Download
Collections
Policy Notes